Kearns Evan sold COGT
December 17, 2025 · Form 4 insider transaction
Kearns Evan sold 125,602 shares of Cogent Biosciences, Inc. at $39.45 per share, a transaction worth $4.95M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
125,602
Price
$39.45
Total value
$4.95M
InsiderKearns Evan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after174,398
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs.; Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.